PATENT CLAIM ANALYSIS

Application Number: 15777952
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "464000"]

Abstract:
A pharmaceutical composition comprising clobazam or its pharmaceutically acceptable salt(s) or solvate(s) thereof of defined particle size and one or more pharmaceutically acceptable excipients is described. A method for preparing the composition is also described.

Claim (Index 7):
The pharmaceutical composition as claimed in  claim 1 , wherein said pharmaceutically acceptable excipient is selected from the group consisting of pregelatinized starch, starch, sodium croscarmellose, crosslinked polyvinylpyrrolidone, talc, sodium lauryl sulfate, stearic acid, calcium stearate, magnesium stearate, microcrystalline cellulose, lactose monohydrate, starch, mannitol, potassium, chloride, powdered cellulose, sodium chloride, sorbitol hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, colloidal silicon dioxide, croscarmellose sodium, crospovidone and methyl cellulose.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.3871
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11238496', '11776012', '11527501', '13422494', '14917125']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7724781226355611
- 35 USC 102 Novelty (BERT): 0.4886892598537687
- Combined Prediction Score: 0.7440992363573818
- Mean Citation Score: 234.973662
- Max Citation Score: 257.56058
- Similarity Product: 220.347723366164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test